How It Works
The Medicine
The Journey
Our Doctors
Pricing
The Science
The Neuroscience of Ketamine
Ketamine Research
Psychedelic Medicine Pipeline
Blog
Login
Get Started
Home
How it Works
The Medicine
The Journey
Our Doctors
Pricing
Blog
The Science
The Neuroscience of Ketamine
Ketamine Research
Psychedelic Medicine Pipeline
About Us
FAQ
Login
Am I a candidate?
Mindbloom® in the Press
as seen in:
Forbes
January 24, 2022
I Tried At-Home Ketamine For Depression And Anxiety With Mindbloom. Here’s My Experience.
The New York Times
November 5, 2021
The Ketamine Cure
New York Times
January 19, 2021
How Nothingness Became Everything We Wanted
The Founder Podcast
January 12, 2021
Transforming Lives Through Ketamine Therapy
Below The Line
January 6, 2021
The Innovative Future of Psychedelics — Below the Line
Addicted Mind
December 18, 2020
Mindbloom & Psychedelic Medicine with Dylan Beynon
Previous
Load More
Ketamine and Psychedelic Therapy News
The New York Times
September 4, 2019
Johns Hopkins Opens New Center for Psychedelic Research
National Institute of Mental Health
August 13, 2019
New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine
Forbes
June 14, 2019
How Ketamine Opens a New Era for Depression Treatment
Psychiatry Advisor
March 19, 2019
Ketamine: A Promising Novel Therapy for Anxiety and PTSD
Load More
Contact us at
press@mindbloom.com
Receive actionable mental health tips and the latest psychedelic news delivered to your inbox.
By providing your email address, you consent to receiving marketing messages.
Terms of Use,
Privacy Policy
, and
Notice of Privacy Practices
By providing your email address, you agree to receive marketing messages as per our
Terms of Use,
Privacy Policy
, and
Notice of Privacy Practices
Thank you! Your submission has been received!
Something went wrong.
Press